BioXcel Therapeutics (BTAI) PT Lowered to $83 at BofA Securities

April 1, 2021 6:30 AM EDT
Get Alerts BTAI Hot Sheet
Price: $35.87 -0.42%

Rating Summary:
    11 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 17 | Down: 14 | New: 42
Trade Now! 
Join SI Premium – FREE
BofA Securities analyst Geoff Meacham lowered the price target on BioXcel Therapeutics (NASDAQ: BTAI) to $83.00 (from $85.00) while maintaining a Buy rating.

You May Also Be Interested In





Related Categories

Analyst PT Change